Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases
- PMID: 33517832
- PMCID: PMC8189041
- DOI: 10.1080/21645515.2020.1852009
Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases
Abstract
Background: On August 25, 2019, the Noguchi Memorial Institute for Medical Research notified the confirmation of a circulating-vaccine-derived poliovirus type-2 (cVDPV2) from the Agbogbloshie environmental surveillance (AES) site, in the Greater Accra Region. A field investigation of the outbreak was conducted to describe the results of epidemiological and laboratory investigations, and control efforts.
Methods: We conducted a descriptive investigation, records review, and active-case-search. Caregivers were interviewed on the vaccination status of their children; knowledge, attitude, and practices on polio prevention; water, sanitation and hygiene practices, and health-seeking behaviors. Stool from healthy children <5 y and sewage samples were taken for laboratory diagnosis.
Results: cVDPV2 genetically similar to the cVDPV2 diagnosed recently in the Northern Region of Ghana and Nigeria was identified. 2019 half-year coverage of OPV and IPV was 22%. Fully immunized children were 49% (29/59). Most health workers (70%) had a fair knowledge of polio and acute flaccid paralysis (AFP). Forty-six percent of care-givers admitted to using the large drain linked to the site where the cVDPV2 was isolated as their place of convenience and disposing of the fecal matter of their children. No AFP case was identified. Stool samples from 40 healthy children yielded non-polio enteroviruses while 75% (3/4) of the additional sewage samples yielded cVDPV2.
Conclusion: cVDPV2 was isolated from the AES site. No AFP or poliovirus was identified from healthy children. There is a need to improve health workers' knowledge on AFP and to address the dire sanitation conditions in the Agbogbloshie market and its environs.
Keywords: Agbobloshie – Accra; Ghana; Polio; circulating vaccine-derived poliovirus; mOPV.
Figures
Similar articles
-
Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019.Biomed Res Int. 2024 Oct 4;2024:5515777. doi: 10.1155/2024/5515777. eCollection 2024. Biomed Res Int. 2024. PMID: 39399343 Free PMC article.
-
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.Lancet Infect Dis. 2024 Apr;24(4):427-436. doi: 10.1016/S1473-3099(23)00688-6. Epub 2024 Jan 18. Lancet Infect Dis. 2024. PMID: 38246190
-
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.Lancet Infect Dis. 2022 Feb;22(2):284-294. doi: 10.1016/S1473-3099(21)00453-9. Epub 2021 Oct 11. Lancet Infect Dis. 2022. PMID: 34648733 Free PMC article.
-
Response to Vaccine-Derived Polioviruses Detected through Environmental Surveillance, Guatemala, 2019.Emerg Infect Dis. 2023 Aug;29(8):1524-1530. doi: 10.3201/eid2908.230236. Emerg Infect Dis. 2023. PMID: 37486156 Free PMC article. Review.
-
Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.Epidemiol Infect. 2017 Feb;145(3):413-419. doi: 10.1017/S0950268816002569. Epub 2016 Nov 21. Epidemiol Infect. 2017. PMID: 27866483 Free PMC article. Review.
Cited by
-
First Molecular Detection of SARS-CoV-2 in Sewage and Wastewater in Ghana.Biomed Res Int. 2024 Mar 25;2024:9975781. doi: 10.1155/2024/9975781. eCollection 2024. Biomed Res Int. 2024. PMID: 38595329 Free PMC article.
-
Experience and findings from surveillance peer review in Nigeria, August 2017-May 2019.Pan Afr Med J. 2023 Aug 24;45(Suppl 2):9. doi: 10.11604/pamj.supp.2023.45.2.39450. eCollection 2023. Pan Afr Med J. 2023. PMID: 38370096 Free PMC article.
-
Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination.NPJ Vaccines. 2023 Mar 18;8(1):44. doi: 10.1038/s41541-023-00642-w. NPJ Vaccines. 2023. PMID: 36934085 Free PMC article.
-
Public health concerns surrounding the cVDPV2 outbreak in Africa: Strategies for prevention and control with a special focus on Nigeria.Health Sci Rep. 2023 May 12;6(5):e1269. doi: 10.1002/hsr2.1269. eCollection 2023 May. Health Sci Rep. 2023. PMID: 37187504 Free PMC article.
-
Environmental Monitoring for Enteroviruses in Maputo, Mozambique-2018.Pathogens. 2022 Apr 29;11(5):527. doi: 10.3390/pathogens11050527. Pathogens. 2022. PMID: 35631048 Free PMC article.
References
-
- Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine—live. In: Plotkin SA, Orenstein WA, Offit PA editors. Vaccines. 5th ed. Philadelphia, USA: W.B. Saunders Company; 2008. p. 631–85.
-
- Progress toward the global interruption of wild poliovirus type 2 transmission, 1999. MMWR Morb Mortal Wkly Rep. 1999;48:736–738, 747. - PubMed
-
- Progress toward interruption of wild poliovirus transmission—worldwide, January 2011–March 2012. MMWR Morb Mortal Wkly Rep. 2012;61:353–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical